Gregory Motz

Title: Gregory Motz: Innovator in Selective Protein Degradation

Introduction

Gregory Motz is an accomplished inventor based in Quincy, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of protein degradation. His innovative work has led to the development of a unique patent that addresses important challenges in protein management.

Latest Patents

Motz holds a patent for "Compositions and methods for selective protein degradation." This invention provides compositions that include a fusion polypeptide and methods for creating a fusion polypeptide. The fusion polypeptide consists of a COF1/CRBN-binding polypeptide, COF2/CRBN-binding polypeptide, or COF3/CRBN-binding polypeptide, along with a heterologous polypeptide of interest. This advancement has the potential to impact various applications in therapeutic development.

Career Highlights

Throughout his career, Gregory Motz has worked with notable organizations such as Novartis AG and the University of Pennsylvania. His experience in these prestigious institutions has allowed him to refine his expertise and contribute to groundbreaking research in the field of biotechnology.

Collaborations

Motz has collaborated with esteemed colleagues, including James Bradner and Andrei Alexandrovich Golosov. These partnerships have fostered an environment of innovation and have led to significant advancements in their respective fields.

Conclusion

Gregory Motz is a prominent figure in the realm of selective protein degradation, with a patent that showcases his innovative approach to biotechnology. His collaborations and career experiences further highlight his contributions to the scientific community.